Drawing for QUANTRX

USPTO serial 88424781

QUANTRX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SALCIDO, JOHN CHARLES
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QUANTRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory K. Scott, Ph.D., J.D.

Gregory K. Scott, Ph.D., J.D. KLARQUIST SPARKMAN, LLP121 SW SALMON STREETONE WORLD TRADE CENTER, SUITE 1600PORTLAND, OR 97204

Goods and services

ClassDescriptionStatusFirst use
005feminine hygiene products, namely, pads, interlabial pads; test kits for home and office use, namely, pregnancy and ovulation test kit; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; quantitative and semi-quantitative tests consisting of medical diagnostic test strips and diagnostic reagents for testing for the presence of infectious, hormonal, metabolic and toxic analytes, namely, fertility, osteoporosis, cancer, bacterial and fungal infection, steroid hormones, cardiac markers, genetic markers, fetal blood, urine and oral fluid, and presence of drugs, for medical laboratory use, medical use and home useACTIVE—
009laboratory supplies, namely, test tubes and centrifuge tubesACTIVE—
010medical specimen collection devices for collecting vaginal and anal secretions for diagnostic analysis, namely, glass slides, cups, and bags; Medical diagnostic instruments for the analysis of body fluids in the nature of lateral flow devices, namely, urine, blood and oral fluid testing device for medical laboratory use, medical use and home use; drug delivery systems; transdermal drug delivery patches sold without medicationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 16, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 16, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 14, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 28, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 13, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 9, 2022DOCKASSIGNED TO EXAMINER—
Jun 17, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 27, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 20, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 2, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 28, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 28, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 26, 2020ALIEASSIGNED TO LIE—
Feb 24, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 24, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Feb 24, 2020CNSLSUSPENSION LETTER WRITTEN—
Feb 1, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 31, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 31, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2019DOCKASSIGNED TO EXAMINER—
May 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance